MARKET

LLY

LLY

Lilly Eli & Co
NYSE
330.01
-4.37
-1.31%
After Hours: 331.50 +1.49 +0.45% 19:59 09/29 EDT
OPEN
333.97
PREV CLOSE
334.38
HIGH
334.68
LOW
327.27
VOLUME
3.74M
TURNOVER
0
52 WEEK HIGH
341.70
52 WEEK LOW
221.10
MARKET CAP
313.57B
P/E (TTM)
52.66
1D
5D
1M
3M
1Y
5Y
Biogen, Eisai cool off after massive run-up following lecanemab Alzheimer's data
The juggernaut rise in the stock prices of Biogen (NASDAQ:BIIB) and E...
Seekingalpha · 13h ago
LLY & PRTA in Spotlight on BIIB-Eisai's AD Drug Data
The success of Biogen (BIIB)-Eisai's AD candidate in a big phase III study makes investors optimistic about the prospects of other AD candidates as well.
Zacks · 17h ago
The Oncology Institute Enrolls Nation's First 2 Patients In Phase 3 Open-Label, Randomized Clinical Trial Of Pirtobrutinib
The Oncology Institute, Inc. (NASDAQ:TOI), today announces the enrollment of two of its patients as the first and second patients dosed in the United States in a phase 3 open-label, randomized study of Pirtobrutinib
Benzinga · 19h ago
Oncology Institute Enrolls First Two Patients in US in Late-Stage Cancer Treatment Trial
Oncology Institute Enrolls First Two Patients in US in Late-Stage Cancer Treatment Trial
MT Newswires · 21h ago
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.
Benzinga · 22h ago
Netflix, Biogen And Other Big Gainers From Wednesday
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.
Benzinga · 23h ago
Many Alzheimer's drug developers close significantly higher thanks to Biogen, Eisai data
Biogen (NASDAQ:BIIB) and Eisai (<a href="https://seekingalpha.com/symbol/ES...
Seekingalpha · 1d ago
Dow Jones Jumps 549 Points As Treasury Yields Tumble, But Now What? Eli Lilly Leads 7 Bullish Stocks
The major indexes rebounded as Treasury yields tumbled from 4% as the Bank of England resumed bond buying. Eli Lilly led stocks showing bullish action. Here's what to do now.
Investor's Business Daily · 1d ago
More
About LLY
Eli Lilly and Company is engaged in a drug manufacturing business. The Company discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. Its diabetes products include Basaglar, Humalog, Humulin, Jardiance, Trajenta, and Trulicity. Its oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. Its immunology products include Olumiant, Baricitinib, and Taltz. Its neuroscience products include Cymbalta, Emgality, and Zyprexa. Its other therapies consist of Bamlanivimab and etesevimab, Bebtelovimab, Cialis, and Forteo. It maintains special business groups to service wholesalers, pharmacy benefit managers, managed care organizations, group purchasing organizations, government and long-term care institutions, hospitals, and certain retail pharmacies. It manufactures and distributes its products through facilities in the United States, including Puerto Rico, and other countries. Its products are sold in about 120 countries.

Webull offers kinds of Eli Lilly And Co stock information, including NYSE:LLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LLY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LLY stock methods without spending real money on the virtual paper trading platform.